Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Dtsch Arztebl Int ; 114(35-36): 589-596, 2017 Sep 04.
Article in English | MEDLINE | ID: mdl-28927497

ABSTRACT

BACKGROUND: A decision-to-delivery interval (DDI) of no more than 20 minutes has long been considered a requirement for cesarean sections, even though there have hardly been any studies on this topic. We retrospectively investigated data relevant to DDI for emergency cesarean sections performed for the most common indications, namely, suspected and documented fetal asphyxia. METHODS: We analyzed data on emergency in-hospital cesarean sections in the period 2008-2015. Low 5- and 10-minute Apgar scores (a scheme with points awarded for breathing, heart rate, muscle tone, skin coloration, and the elicitability of reflexes) were the primary endpoints; acid-base status in arterial cord blood and in-hospital neonatal death were the secondary endpoints. The raw analysis was supplemented by an analysis adjusted for various factors including gestational age, maternal age, and obstetrical presentation. RESULTS: Data from 39 291 neonates were included. The DDI was up to 10 minutes in 64.6% of cases, from 11 to 20 minutes in 34.3%, and over 20 minutes in 1.1%. Low Apgar scores were less common in children whose emergency cesarean sections were performed within 10 minutes or within 20 minutes. For example, the adjusted odds ratio for a 10-minute Apgar score below 4 was 0.49 (95% confidence interval [0.25; 0.96] when a DDI of more than 20 minutes was used as the reference criterion. CONCLUSION: This is the largest population-based, risk-adjusted analysis to be carried out on this topic to date. It reveals, for the first time, an association between DDI of 20 minutes or less and the avoidance of outcomes that are dangerous to the child. As it is not possible to predict such obstetrical emergencies in advance, it seems reasonable to ensure the availability of caredelivery structures that make it possible for emergency cesarean sections to be performed within 20 minutes of the decision to do so.


Subject(s)
Cesarean Section , Decision Making , Emergencies , Apgar Score , Asphyxia Neonatorum , Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Outcome , Retrospective Studies , Time Factors
2.
Int Urogynecol J ; 22(3): 293-8, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21153470

ABSTRACT

INTRODUCTION AND HYPOTHESIS: Several modifications of sacrospinous ligament fixation (SLF) are described. METHODS: This study presents a standardised SLF technique. Perioperative course and outcome are compared retrospectively after surgery is performed by experienced surgeons or by residents. RESULTS: Two hundred three SLF were analysed. Eight residents (LO) operated on 41 patients (5.1 ± 2.2). Six experienced surgeons (SO) operated on 162 patients (27.0 ± 25.7). Mean operating time was 67 ± 33 min. (LO 99 ± 45 min vs. SO 59 ± 22 min, p < 0.05). The overall morbidity rate was 7.8%. There was no significant difference regarding complications and outcomes between SO and LO. CONCLUSIONS: Operation time was longer but outcomes were identical, and morbidity rate was not increased in the group of resident surgeons. In comparison to literature, complication rate was low. SLF should be part of residency programmes.


Subject(s)
Education, Medical, Continuing , Gynecologic Surgical Procedures/methods , Internship and Residency , Ligaments/surgery , Pelvic Organ Prolapse/surgery , Vagina/surgery , Aged , Clinical Competence , Female , Humans , Middle Aged , Retrospective Studies , Sutures , Time Factors , Treatment Outcome
3.
Arzneimittelforschung ; 52(9): 706-15, 2002.
Article in English | MEDLINE | ID: mdl-12404887

ABSTRACT

This randomised, double-blind, multicentric clinical study compared the efficacy and tolerability of the two vaginal antiseptics, 10 mg dequalinium chloride (CAS 522-51-0, Fluomycin N) and 200 mg povidone iodine (CAS 25655-41-8), in a parallel-group design. A total of 180 patients with vaginal infections of varying etiology participated in this study (bacterial vaginosis, fluor vaginalis, vulvo-vaginal candidiasis, trichomoniasis). Patients were randomly allocated to one of the two treatment groups and were treated once per day for 6 days. Control examinations took place 5 to 7 days after the end of treatment, and 3 to 4 weeks after the first control examination. The total symptoms score, a summary score for the clinical symptoms, discharge, burning, pruritus, redness of vulva/vagina, was defined as primary efficacy parameter. The treatments at the first control examination were compared in the full analysis set using the Wilcoxon-Mann-Whitney U-test, 2-sided, thereby proving equivalence of both treatments at the 5% level. Both treatments strongly improved the symptoms of vaginal infections both on short-term and long-term follow-up. Descriptive analysis of the secondary parameters, vaginal pH, degree of purity of the vaginal flora, and number of lactobacilli in the wet mounts, supported the comparable efficacy of both therapies to restore the vaginal milieu. Analysis of the diagnostic subgroups indicated that irrespective of the diagnosis, both treatments improved the efficacy criteria as observed for the entire population. The global assessment of the therapeutic efficacy by investigators and patients supported the results of the efficacy analysis with good to very good ratings in 70-90% of the cases. A good tolerability of both preparations was observed in this study with a low number of adverse events in the test group (5.8%).


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Dequalinium/therapeutic use , Povidone-Iodine/therapeutic use , Vaginal Diseases/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/adverse effects , Candidiasis, Vulvovaginal/drug therapy , Candidiasis, Vulvovaginal/microbiology , Dequalinium/administration & dosage , Dequalinium/adverse effects , Double-Blind Method , Female , Humans , Hydrogen-Ion Concentration , Middle Aged , Povidone-Iodine/administration & dosage , Povidone-Iodine/adverse effects , Trichomonas Infections/drug therapy , Trichomonas Infections/microbiology , Vaginal Discharge/microbiology , Vaginal Diseases/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...